Search Options
Exit

Search Options

View Results
Clear All
380-23 | Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

Trial Number: 380-23

Condition: Pediatric Cancer

Conducted at: Miller Children’s & Women’s Hospital Long Beach

Participant Age Range: 1 year and older

Participant Gender: Any

Enrolling Participants: Yes

Learn More
404-23 | Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma

Trial Number: 404-23

Condition: Pediatric Cancer

Conducted at: Miller Children’s & Women’s Hospital Long Beach

Participant Age Range: 1 year to 30 years

Participant Gender: Any

Enrolling Participants: Yes

Learn More
351-23 | A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Trial Number: 351-23

Conditions: Pediatric Cancer, Brain Tumor

Conducted at: Miller Children’s & Women’s Hospital Long Beach

Participant Age Range: 3 years to 22 years

Participant Gender: Any

Enrolling Participants: Yes

Learn More
346-23 | Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Trial Number: 346-23

Condition: Pediatric Cancer

Conducted at: Miller Children’s & Women’s Hospital Long Beach

Participant Age Range: up to 21 Years

Participant Gender: Any

Enrolling Participants: Yes

Learn More
217-21 | A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

Trial Number: 217-21

Conditions: Pediatric Cancer, Lymphoma

Conducted at: Miller Children’s & Women’s Hospital Long Beach

Participant Age Range: up to 2 Years

Participant Gender: Any

Enrolling Participants: Yes

Learn More
216-21 | A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, and Cyclophosphamide (VINO-AC) Plus Maintenance Chemotherapy With Vinorelbine and Oral Cyclophosphamide (VINO-CPO) vs Vincristine, Dactinomycin and Cyclophosphamide (VAC) Plus VINO-CPO...

Trial Number: 216-21

Condition: Pediatric Cancer

Conducted at: Miller Children’s & Women’s Hospital Long Beach

Participant Age Range: up to 50 Years

Participant Gender: Any

Enrolling Participants: Yes

Learn More
Contact Us
Our researchers are ready to help, contact us for any questions or assistance you might need.
Contact Research & Clinical Trials
About Clinical Trials
Clinical trials have a critical role in bringing new and more effective drugs, devices and tests into our lives. However it may be difficult for patients to decide whether a specific clinical trial is right for them.
Learn More